Clinical Trial to Assess the Effect of Testosterone in Patients With Poor Ovarian Response (TESTOPRIM)

PHASE3CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

February 11, 2019

Study Completion Date

February 11, 2019

Conditions
Infertility, Female
Interventions
DRUG

GROUP 1: Long testosterone

Application of testosterone in transdermal gel during the 2 cycles prior to initiation of controlled ovarian stimulation and until the onset of second menstruation (approximately 56 days). The COS begins the day after the last testosterone application

DRUG

GROUP 2: Short testosterone

Application of testosterone in transdermal gel begins on day 21 of menstrual cycle, from the luteal phase of the cycle prior to initiation of controlled ovarian stimulation and until menstruation (approximately 10 days). The COS begins the day after the last testosterone application.

DRUG

GROUP 3: Control

The COS starts directly on the second day of the cycle without prior medication.

Trial Locations (1)

46026

Hospital Universitario y Politécnico La Fe, Valencia

All Listed Sponsors
lead

Instituto de Investigacion Sanitaria La Fe

OTHER

NCT03378713 - Clinical Trial to Assess the Effect of Testosterone in Patients With Poor Ovarian Response (TESTOPRIM) | Biotech Hunter | Biotech Hunter